Cite
HARVARD Citation
Harrison, P. et al. (n.d.). PO.6.131 A randomized, double-blind, placebo controlled study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-303, a potent dual baff/april inhibitor, in adult healthy volunteers. Lupus science & medicine. pp. A99-A100. [Online].